Cargando…
Body composition on low dose chest CT is a significant predictor of poor clinical outcome in COVID-19 disease - A multicenter feasibility study
PURPOSE: Low-dose computed tomography (LDCT) of the chest is a recommended diagnostic tool in early stage of COVID-19 pneumonia. High age, several comorbidities as well as poor physical fitness can negatively influence the outcome within COVID-19 infection. We investigated whether the ratio of fat t...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480673/ https://www.ncbi.nlm.nih.gov/pubmed/32961451 http://dx.doi.org/10.1016/j.ejrad.2020.109274 |
_version_ | 1783580456104493056 |
---|---|
author | Kottlors, Jonathan Zopfs, David Fervers, Philipp Bremm, Johannes Abdullayev, Nuran Maintz, David Tritt, Stephanie Persigehl, Thorsten |
author_facet | Kottlors, Jonathan Zopfs, David Fervers, Philipp Bremm, Johannes Abdullayev, Nuran Maintz, David Tritt, Stephanie Persigehl, Thorsten |
author_sort | Kottlors, Jonathan |
collection | PubMed |
description | PURPOSE: Low-dose computed tomography (LDCT) of the chest is a recommended diagnostic tool in early stage of COVID-19 pneumonia. High age, several comorbidities as well as poor physical fitness can negatively influence the outcome within COVID-19 infection. We investigated whether the ratio of fat to muscle area, measured in initial LDCT, can predict severe progression of COVID-19 in the follow-up period. METHOD: We analyzed 58 individuals with confirmed COVID-19 infection that underwent an initial LDCT in one of two included centers due to COVID-19 infection. Using the ratio of waist circumference per paravertebral muscle circumference (FMR), the body composition was estimated. Patient outcomes were rated on an ordinal scale with higher numbers representing more severe progression or disease associated complications (hospitalization/ intensive care unit (ICU)/ tracheal intubation/ death) within a follow-up period of 22 days after initial LDCT. RESULTS: In the initial LDCT a significantly higher FMR was found in patients requiring intensive care treatment within the follow-up period. In multivariate logistic regression analysis, FMR (p < .001) in addition to age (p < .01), was found to be a significant predictor of the necessity for ICU treatment of COVID-19 patients. CONCLUSION: FMR as potential surrogate of body composition and obesity can be easily determined in initial LDCT of COVID-19 patients. Within the multivariate analysis, in addition to patient age, low muscle area in proportion to high fat area represents an additional prognostic information for the patient outcome and the need of an ICU treatment during the follow-up period within the next 22 days. This multicentric pilot study presents a method using an initial LDCT to screen opportunistically for obese patients who have an increased risk for the need of ICU treatment. While clinical capacities, such as ICU beds and ventilators, are more crucial than ever to help manage the current global corona pandemic, this work introduces an approach that can be used for a cost-effective way to help determine the amount of these rare clinical resources required in the near future. |
format | Online Article Text |
id | pubmed-7480673 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-74806732020-09-09 Body composition on low dose chest CT is a significant predictor of poor clinical outcome in COVID-19 disease - A multicenter feasibility study Kottlors, Jonathan Zopfs, David Fervers, Philipp Bremm, Johannes Abdullayev, Nuran Maintz, David Tritt, Stephanie Persigehl, Thorsten Eur J Radiol Research Article PURPOSE: Low-dose computed tomography (LDCT) of the chest is a recommended diagnostic tool in early stage of COVID-19 pneumonia. High age, several comorbidities as well as poor physical fitness can negatively influence the outcome within COVID-19 infection. We investigated whether the ratio of fat to muscle area, measured in initial LDCT, can predict severe progression of COVID-19 in the follow-up period. METHOD: We analyzed 58 individuals with confirmed COVID-19 infection that underwent an initial LDCT in one of two included centers due to COVID-19 infection. Using the ratio of waist circumference per paravertebral muscle circumference (FMR), the body composition was estimated. Patient outcomes were rated on an ordinal scale with higher numbers representing more severe progression or disease associated complications (hospitalization/ intensive care unit (ICU)/ tracheal intubation/ death) within a follow-up period of 22 days after initial LDCT. RESULTS: In the initial LDCT a significantly higher FMR was found in patients requiring intensive care treatment within the follow-up period. In multivariate logistic regression analysis, FMR (p < .001) in addition to age (p < .01), was found to be a significant predictor of the necessity for ICU treatment of COVID-19 patients. CONCLUSION: FMR as potential surrogate of body composition and obesity can be easily determined in initial LDCT of COVID-19 patients. Within the multivariate analysis, in addition to patient age, low muscle area in proportion to high fat area represents an additional prognostic information for the patient outcome and the need of an ICU treatment during the follow-up period within the next 22 days. This multicentric pilot study presents a method using an initial LDCT to screen opportunistically for obese patients who have an increased risk for the need of ICU treatment. While clinical capacities, such as ICU beds and ventilators, are more crucial than ever to help manage the current global corona pandemic, this work introduces an approach that can be used for a cost-effective way to help determine the amount of these rare clinical resources required in the near future. Elsevier B.V. 2020-11 2020-09-09 /pmc/articles/PMC7480673/ /pubmed/32961451 http://dx.doi.org/10.1016/j.ejrad.2020.109274 Text en © 2020 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Research Article Kottlors, Jonathan Zopfs, David Fervers, Philipp Bremm, Johannes Abdullayev, Nuran Maintz, David Tritt, Stephanie Persigehl, Thorsten Body composition on low dose chest CT is a significant predictor of poor clinical outcome in COVID-19 disease - A multicenter feasibility study |
title | Body composition on low dose chest CT is a significant predictor of poor clinical outcome in COVID-19 disease - A multicenter feasibility study |
title_full | Body composition on low dose chest CT is a significant predictor of poor clinical outcome in COVID-19 disease - A multicenter feasibility study |
title_fullStr | Body composition on low dose chest CT is a significant predictor of poor clinical outcome in COVID-19 disease - A multicenter feasibility study |
title_full_unstemmed | Body composition on low dose chest CT is a significant predictor of poor clinical outcome in COVID-19 disease - A multicenter feasibility study |
title_short | Body composition on low dose chest CT is a significant predictor of poor clinical outcome in COVID-19 disease - A multicenter feasibility study |
title_sort | body composition on low dose chest ct is a significant predictor of poor clinical outcome in covid-19 disease - a multicenter feasibility study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480673/ https://www.ncbi.nlm.nih.gov/pubmed/32961451 http://dx.doi.org/10.1016/j.ejrad.2020.109274 |
work_keys_str_mv | AT kottlorsjonathan bodycompositiononlowdosechestctisasignificantpredictorofpoorclinicaloutcomeincovid19diseaseamulticenterfeasibilitystudy AT zopfsdavid bodycompositiononlowdosechestctisasignificantpredictorofpoorclinicaloutcomeincovid19diseaseamulticenterfeasibilitystudy AT ferversphilipp bodycompositiononlowdosechestctisasignificantpredictorofpoorclinicaloutcomeincovid19diseaseamulticenterfeasibilitystudy AT bremmjohannes bodycompositiononlowdosechestctisasignificantpredictorofpoorclinicaloutcomeincovid19diseaseamulticenterfeasibilitystudy AT abdullayevnuran bodycompositiononlowdosechestctisasignificantpredictorofpoorclinicaloutcomeincovid19diseaseamulticenterfeasibilitystudy AT maintzdavid bodycompositiononlowdosechestctisasignificantpredictorofpoorclinicaloutcomeincovid19diseaseamulticenterfeasibilitystudy AT trittstephanie bodycompositiononlowdosechestctisasignificantpredictorofpoorclinicaloutcomeincovid19diseaseamulticenterfeasibilitystudy AT persigehlthorsten bodycompositiononlowdosechestctisasignificantpredictorofpoorclinicaloutcomeincovid19diseaseamulticenterfeasibilitystudy |